Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chinese Medical Journal is Scopus-indexed (Q1, CiteScore 10.9), WoS SCIE, DOAJ. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 0366-6999Verify ISSN ↗2542-5641Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 31 / 669 | 95th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1973–present (also 1962–1966, 1946–1960), best quartile Q1, CiteScore 10.9.
Chinese Medical Journal is Q1 in Medicine (all) (rank 31 of 669), by CiteScore 2025.
Chinese Medical Journal is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.9, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.661, quartile Q1, with an H-index of 92.
The publisher lists an article processing charge of about US$2,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Chinese Medical Journal is published by Lippincott Williams and Wilkins. Its print ISSN is 0366-6999 and its online ISSN is 2542-5641.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Chinese Medical Journal has an h-index of 93 and a 2-year mean of 4.82 citations per paper (OpenAlex). Its Scopus CiteScore is 10.9, quartile Q1. On 2-year citations it ranks #45 of 646 Scopus journals in Medicine (all).
Chinese Medical Journal published 518 papers in 2025; its busiest recent year was 2020 with 678. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (90.9%), Hong Kong SAR China (3.3%) and Australia (2.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 9 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.